Filing Details

Accession Number:
0000791908-14-000045
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-20 15:38:32
Reporting Period:
2014-03-18
Filing Date:
2014-03-20
Accepted Time:
2014-03-20 15:38:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 942756657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1210905 D Paul Rubin C/O Xoma Corporation
2910 Seventh Street
Berkeley CA 94710
Sr. Vp Clinical Dev. & Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2014-03-18 12,142 $0.00 84,163 No 4 M Direct
Common Shares Disposition 2014-03-18 4,661 $6.32 79,502 No 4 S Direct
Common Shares Acquisiton 2014-03-18 18,205 $0.00 97,707 No 4 M Direct
Common Shares Disposition 2014-03-18 6,988 $6.32 90,719 No 4 S Direct
Common Shares Acquisiton 2014-03-18 6,000 $3.04 96,719 No 4 M Direct
Common Shares Disposition 2014-03-18 6,000 $6.31 90,719 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Incentive Share Option (right to buy) Disposition 2014-03-18 6,000 $3.04 6,000 $3.04
Common Shares Restricted Stock Units Disposition 2014-03-18 12,142 $0.00 12,142 $0.00
Common Shares Restricted Stock Units Disposition 2014-03-18 18,205 $0.00 18,205 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
92,040 2021-05-31 No 4 M Direct
24,282 2014-03-18 2016-03-18 No 4 M Direct
18,205 2014-03-18 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 5,310 Indirect by 401(k)
Footnotes
  1. These restricted stock units were granted on February 28, 2013 and are scheduled to vest in substantially equal installments on each of March 18, 2014, March 18, 2015, and March 18, 2016.
  2. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This nondiscretionary transaction represents the settlement of vested restricted stock units in shares of common stock.
  3. Shares sold on the open market to satisfy the minimum amount of taxes required to be withheld in connection with the vesting of the shares in a non-discretionary transaction pursuant to the reporting person's agreement under the Company's equity incentive plan.
  4. These restricted stock units are scheduled to vest in substantially equal installments annually over three years, with the first installment vesting on March 18, 2013.
  5. This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on 3/20/2013.
  6. This transaction was executed in multiple trades ranging at prices from $6.16 to $6.41.The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected.
  7. Incentive Stock Option exercisable in conjunction with matching Non-Qualified Stock Option as to (a) 25% of the option shares upon the first anniversary of the date of grant, and (b) the remaining 75% of the option shares in thirty-six (36) equal and consecutive monthly installments beginning one year and one month after the date of grant.